LightUp launch for fluorescent probe technology:
This article was originally published in Clinica
LightUp Technologies, of Huddinge, Sweden, plans to release DNA analysis products, including diagnostic assays, using fluorescence-based technology licensed from US firm Molecular Probes. The LightUp probe products, scheduled for launch in May 2003, can identify and quantify bacteria, viruses and other pathogens via the detection and analysis of DNA. Molecular Probes, of Eugene, Oregon, will supply fluorescent stains for the probe assays, which increase sensitivity in detecting DNA and other nucleic acids.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.